Handa Pharmaceuticals, Inc. (TPEX: 6620)
Health Care · Pharmaceuticals · TW
NT$75.00
-3.10% today · -9.3% 1Y
Handa Pharmaceuticals, Inc. (TPEX: 6620) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $392.23M and employs 15 people.
Over the last twelve months the share price has lost 9.3%, trading between 64.10 and 154.00.
Tweenvest scores Handa Pharmaceuticals, Inc. across four factors: quality 77/100, value 72/100, dividend 38/100. Its strongest factor is quality.
6620 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $392.23M
- Revenue (TTM)
- $38.06M
- P/E
- 24.82
- EPS
- 3.02
- Dividend yield
- 2.67%
- Beta (5Y)
- 0.67
- 52-week high
- NT$154.00
- 52-week low
- NT$64.10
- Avg volume (3M)
- —
- Shares outstanding
- 166.53M
- Employees
- 15
- Next earnings
- —
About Handa Pharmaceuticals, Inc.
Handa Pharmaceuticals, Inc. operates as a specialized drug company, concentrating its efforts on creating and advancing new medications for diverse health issues across both the United States and China. The firm currently offers Quetiapine XR, a treatment for Schizophrenia, as well as Dexlansoprazole DR capsules. Beyond its existing portfolio, Handa is actively cultivating a robust pipeline of therapies. This includes their cutting-edge ONCORE drug delivery platform, engineered to boost patient adherence and improve the safety of tyrosine kinase inhibitor oncology drugs. Other significant projects encompass a 505(b)(2)NDA therapeutic agent, Tascenso ODT for managing multiple sclerosis, and the oncology candidates HND-033 and HND-027. Furthermore, the company's development initiatives feature HND-004, designed for diabetic patients; HND-032, intended to aid in smoking cessation; and HND-026, a gastrointestinal medication. Founded in 2014, Handa Pharmaceuticals, Inc. has its main corporate headquarters situated in Tainan City, Taiwan.
- ISIN
- TW0006620008
- Founded
- 2014
- Listed since
- Dec 30, 2016
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | 0.00% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.18 | +0.01% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.24 | -0.13% |
| Roche Holding AGSWX: ROP | $371.62B | CHF370.90 | -0.78% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.18 | -1.27% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.52 | -0.18% |
Figures last refreshed Aug 18, 2026.